Stegnar M - Search Results

1

Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.

Blinc A, Kozak M, Sabovic M, Božic M, Stegnar M, Poredoš P, Kravos A, Barbic-Žagar B, Pohar Perme M, Stare J; PID-PAB Investigators. Blinc A, et al. Among authors: stegnar m. Int Angiol. 2011 Dec;30(6):555-66. Int Angiol. 2011. PMID: 22233617

2

Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease.

Blinc A, Kozak M, Šabovič M, Božič Mijovski M, Stegnar M, Poredoš P, Kravos A, Barbič-Žagar B, Stare J, Pohar Perme M. Blinc A, et al. Among authors: stegnar m. Int Angiol. 2017 Jun;36(3):216-227. doi: 10.23736/S0392-9590.16.03731-7. Epub 2016 Jun 22. Int Angiol. 2017. PMID: 27332992 Free article.

3

Fibrinolytic parameters and lipoprotein(a) in young women with myocardial infarction.

Salobir B, Sabovic M, Peternel P, Stegnar M. Salobir B, et al. Among authors: stegnar m. Angiology. 2002 Mar-Apr;53(2):157-63. doi: 10.1177/000331970205300205. Angiology. 2002. PMID: 11952105

4

Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.

Poredos P, Stegnar M, Gacnik A. Poredos P, et al. Among authors: stegnar m. Vasa. 1999 May;28(2):106-11. doi: 10.1024/0301-1526.28.2.106. Vasa. 1999. PMID: 10409921

5

Do haemostasis activation markers that predict cardiovascular disease exist?

Stegnar M, Vene N, Bozic M. Stegnar M, et al. Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):302-8. doi: 10.1159/000083818. Pathophysiol Haemost Thromb. 2003. PMID: 15692233 Review.

6

Nurr1 haplotypes are associated with femoropopliteal restenosis/re-occlusion after percutaneous transluminal angioplasty.

Božič-Mijovski M, Bedenčič M, Stegnar M, Salapura V, Ježovnik MK, Kozak M, Blinc A. Božič-Mijovski M, et al. Among authors: stegnar m. Eur J Vasc Endovasc Surg. 2012 Mar;43(3):337-8. doi: 10.1016/j.ejvs.2011.12.002. Epub 2012 Jan 9. Eur J Vasc Endovasc Surg. 2012. PMID: 22230598 Free article.

7

D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.

Bozic M, Blinc A, Stegnar M. Bozic M, et al. Among authors: stegnar m. Thromb Res. 2002 Nov 1;108(2-3):107-14. doi: 10.1016/s0049-3848(03)00007-0. Thromb Res. 2002. PMID: 12590945

8

Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism.

Bozic M, Stegnar M, Fermo I, Ritonja A, Peternel P, Stare J, D'Angelo A. Bozic M, et al. Among authors: stegnar m. Thromb Res. 2000 Nov 15;100(4):271-8. doi: 10.1016/s0049-3848(00)00324-8. Thromb Res. 2000. PMID: 11113270

9

Do baseline serum leptin levels predict weight regain after dieting in obese women?

Mavri A, Stegnar M, Sabovic M. Mavri A, et al. Among authors: stegnar m. Diabetes Obes Metab. 2001 Aug;3(4):293-6. doi: 10.1046/j.1463-1326.2001.00134.x. Diabetes Obes Metab. 2001. PMID: 11520310

10

Validation of an automated immunoturbidimetric assay for measurement of plasma D-dimer.

Bozic M, Stegnar M. Bozic M, et al. Among authors: stegnar m. Clin Chem Lab Med. 2003 Jul;41(7):958-62. doi: 10.1515/CCLM.2003.146. Clin Chem Lab Med. 2003. PMID: 12940525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters